Table 2. Analysis of ClassII HLA and its association with rheumatoid arthritis^*.

Generic HLA Class II	RA patients	Controls	p	OR	95% Confidence Interval
	(n = 132)	(n = 218)
DRB1 * 01	29	31	0.1019	1.61	0.95–2.74
DRB1 * 0301	13	25	0.7748	0.8515	0.43–1.70
DRB1 * 0302	2	6	0.7044	0.5471	0.11–2.73
DRB1 * 04	64	63	0.0016	1.8946	1.23–2.79
DRB1 * 07	17	44	0.1279	0.6132	0.34–1.10
DRB1 * 08	21	51	0.1466	0.6524	0.38–1.11
DRB1 * 09	6	12	0.8869	0.8217	0.30–2.21
DRB1 * 10	9	4	0.0377	3.8118	1.16–12.50
DRB1 * 11	14	40	0.0865	0.5544	0.30–1.03
DRB1 * 12	1	2	0.6599	0.8251	–
DRB1 * 13	25	44	0.8912	0.9319	0.56–1.56
DRB1 * 14	20	30	0.8457	1.1093	0.61–2.00
DRB1 * 15	20	30	0.8457	2.1093	0.61–2.00
DRB1 * 16	9	34	0.0291	0.4173	0.20–0.88
DRB3 *	66	128	0.2455	0.8021	0.57–1.13
DRB4 *	81	111	0.1574	1.2960	0.92–1.81
DRB5 *	25	61	0.0995	0.6430	0.40–1.05
DQB1 * 02	28	57	0.3957	0.7889	0.49–1.28
DQB1 * 0301	58	99	0.8942	0.9584	0.66–1.38
DQB1 * 0302	56	54	0.0027	1.9046	1.30–2.90
DQB1 * 0303	3	19	0.0320	0.2523	0.07–0.90
DQB1 * 04	19	47	0.1502	0.6419	0.37–1.12
DQB1 * 05	44	49	0.0529	1.5796	1.02–2.45
DQB1 * 06	32	72	0.1405	0.6973	0.44–1.10

^*χ²test, significance level p<0.05.